Blood-brain barrier dysfunction in mice induced by lipopolysaccharide is attenuated by dapsone

Biochemical and Biophysical Research Communications

Volumn 453, Issue 3, 2014, Pages 419-424

  Zhou, Ting ^a   Zhao, Lei ^a   Zhan, Rui ^a   He, Qihua ^b   Tong, Yawei ^a   Tian, Xiaosheng ^a   Wang, Hecheng ^a   Zhang, Tao ^a   Fu, Yaoyun ^a   Sun, Yang ^a   Xu, Feng ^b   Guo, Xiangyang ^c   Fan, Dongsheng ^c   Han, Hongbin ^c   Chui, Dehua ^a,c  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Blood brain barrier integrity; Dapsone; Lipopolysaccharide

Indexed keywords

CLAUDIN 5; DAPSONE; LIPOPOLYSACCHARIDE; OCCLUDIN; PROTEIN ZO1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TIGHT JUNCTION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD BRAIN BARRIER DYSFUNCTION; BRAIN BLOOD VESSEL; BRAIN DYSFUNCTION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; IN VIVO STUDY; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; METABOLISM;

MUS;

ANIMALS; BLOOD-BRAIN BARRIER; DAPSONE; FEMALE; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; REACTIVE OXYGEN SPECIES;

EID: 84918578607     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.09.093     Document Type: Article

References (40)

1. B.V. Zlokovic, The blood-brain barrier in health and chronic neurodegenerative disorders, Neuron 57 (2008) 178-201.
2. N.J. Abbott, A.A. Patabendige, D.E. Dolman, S.R. Yusof, D.J. Begley, Structure and function of the blood-brain barrier, Neurobiol. Dis. 37 (2010) 13-25.
3. R.D. Bell, E.A. Winkler, I. Singh, A.P. Sagare, R. Deane, Z. Wu, D.M. Holtzman, C. Betsholtz, A. Armulik, J. Sallstrom, B.C. Berk, B.V. Zlokovic, Apolipoprotein E controls cerebrovascular integrity via cyclophilin A, Nature 485 (2012) 512-516.
4. A. Joutel, M. Monet-Lepretre, C. Gosele, C. Baron-Menguy, A. Hammes, S. Schmidt, B. Lemaire-Carrette, V. Domenga, A. Schedl, P. Lacombe, N. Hubner, Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease, J. Clin. Invest. 120 (2010) 433-445.
5. M. Ujiie, D.L. Dickstein, D.A. Carlow, W.A. Jefferies, Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model, Microcirculation 10 (2003) 463-470.
6. A.G. de Boer, P.J. Gaillard, Blood-brain barrier dysfunction and recovery, J. Neural. Trans. 113 (2006) 455-462.
7. N. Weiss, F. Miller, S. Cazaubon, P.O. Couraud, The blood-brain barrier in brain homeostasis and neurological diseases, Biochim. Biophys. Acta 1788 (2009) 842-857.
8. S.M. Seok, J.M. Kim, T.Y. Park, E.J. Baik, S.H. Lee, Fructose-1,6-bisphosphate ameliorates lipopolysaccharide-induced dysfunction of blood-brain barrier, Arch. Pharm. Res. 36 (2013) 1149-1159.
9. S. Chrissobolis, F.M. Faraci, The role of oxidative stress and NADPH oxidase in cerebrovascular disease, Trends Mol. Med. 14 (2008) 495-502.
10. A.A. Miller, G.R. Drummond, T.M. De Silva, A.E. Mast, H. Hickey, J.P. Williams, B.R. Broughton, C.G. Sobey, NADPH oxidase activity is higher in cerebral versus systemic arteries of four animal species: role of Nox2, Am. J. Physiol. Heart Circ. Physiol. 296 (2009) H220-H225.
11. W. Liu, Q. Chen, J. Liu, K.J. Liu, Normobaric hyperoxia protects the blood brain barrier through inhibiting Nox2 containing NADPH oxidase in ischemic stroke, Med. Gas Res. 1 (2011) 22.
12. L. Park, J. Anrather, H. Girouard, P. Zhou, C. Iadecola, Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain, J. Cereb. Blood Flow Metab. 27 (2007) 1908-1918.
13. L. Park, P. Zhou, R. Pitstick, C. Capone, J. Anrather, E.H. Norris, L. Younkin, S. Younkin, G. Carlson, B.S. McEwen, C. Iadecola, Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein, Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 1347-1352.
14. R. Wolf, H. Matz, E. Orion, B. Tuzun, Y. Tuzun, Dapsone, Dermatol. Online J. 8 (2002) 2.
15. A. Diaz-Ruiz, M. Mendez-Armenta, S. Galvan-Arzate, J. Manjarrez, C. Nava-Ruiz, I. Santander, G. Balderas, C. Rios, Antioxidant, anticonvulsive and neuroprotective effects of dapsone and phenobarbital against kainic acid-induced damage in rats, Neurochem. Res. 38 (2013) 1819-1827.
16. A. Diaz-Ruiz, H. Salgado-Ceballos, S. Montes, G. Guizar-Sahagun, N. Gelista-Herrera, M. Mendez-Armenta, S. Diaz-Cintra, C. Rios, Delayed administration of dapsone protects from tissue damage and improves recovery after spinal cord injury, J. Neurosci. Res. 89 (2011) 373-380.
17. A. Diaz-Ruiz, C. Zavala, S. Montes, A. Ortiz-Plata, H. Salgado-Ceballos, S. Orozco-Suarez, C. Nava-Ruiz, I. Perez-Neri, F. Perez-Severiano, C. Rios, Antioxidant, antiinflammatory and antiapoptotic effects of dapsone in a model of brain ischemia/reperfusion in rats, J. Neurosci. Res. 86 (2008) 3410-3419.
18. C. Rios, J. Nader-Kawachi, A.J. Rodriguez-Payan, C. Nava-Ruiz, Neuroprotective effect of dapsone in an occlusive model of focal ischemia in rats, Brain Res. 999 (2004) 212-215.
19. A. Santamaria, J. Ordaz-Moreno, M. Rubio-Osornio, F. Solis-Hernandez, C. Rios, Neuroprotective effect of dapsone against quinolinate- and kainate-induced striatal neurotoxicities in rats, Pharmacol. Toxicol. 81 (1997) 271-275.
20. S.C. Cho, M.C. Park, B. Keam, J.M. Choi, Y. Cho, S. Hyun, S.C. Park, J. Lee, DDS, 4,4′-diaminodiphenylsulfone, extends organismic lifespan, Proc. Natl. Acad. Sci. U.S.A. 107 (2010) 19326-19331.
21. S.C. Cho, J.H. Rhim, H.R. Choi, Y.H. Son, S.J. Lee, K.Y. Song, S.C. Park, Protective effect of 4,4′-diaminodiphenylsulfone against paraquat-induced mouse lung injury, Exp. Mol. Med. 43 (2011) 525-537.
22. S.C. Cho, J.H. Rhim, Y.H. Son, S.J. Lee, S.C. Park, Suppression of ROS generation by 4,4-diaminodiphenylsulfone in non-phagocytic human diploid fibroblasts, Exp. Mol. Med. 42 (2010) 223-232.
23. T. Zhou, Q. He, Y. Tong, R. Zhan, F. Xu, D. Fan, X. Guo, H. Han, S. Qin, D. Chui, Phospholipid transfer protein (PLTP) deficiency impaired blood-brain barrier integrity by increasing cerebrovascular oxidative stress, Biochem. Biophys. Res. Commun. 445 (2014) 352-356.
24. L. Ruiz-Valdepenas, J.A. Martinez-Orgado, C. Benito, A. Millan, R.M. Tolon, J. Romero, Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study, J. Neuroinflammation. 8 (2011) 5.
25. M. Sun, T. Zhou, L. Zhou, Q. Chen, Y. Yu, H. Yang, K. Zhong, X. Zhang, F. Xu, S. Cai, A. Yu, H. Zhang, R. Xiao, D. Xiao, D. Chui, Formononetin protects neurons against hypoxia-induced cytotoxicity through upregulation of ADAM10 and sAbetaPPalpha, J. Alzheimer's Dis. 28 (2012) 795-808.
26. T. Suda, Y. Suzuki, T. Matsui, T. Inoue, O. Niide, T. Yoshimaru, H. Suzuki, C. Ra, T. Ochiai, Dapsone suppresses human neutrophil superoxide production and elastase release in a calcium-dependent manner, Br. J. Dermatol. 152 (2005) 887-895.
27. S. Veszelka, M. Pasztoi, A.E. Farkas, I. Krizbai, T.K. Ngo, M. Niwa, C.S. Abraham, M.A. Deli, Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharide-induced damages, Neurochem. Int. 50 (2007) 219-228.
28. J. Li, L. Ye, X. Wang, J. Liu, Y. Wang, Y. Zhou, W. Ho, (-)-Epigallocatechin gallate inhibits endotoxin-induced expression of inflammatory cytokines in human cerebral microvascular endothelial cells, J. Neuroinflamm. 9 (2012) 161.
29. S. Veszelka, Z. Urbanyi, T. Pazmany, L. Nemeth, I. Obal, N.T. Dung, C.S. Abraham, G. Szabo, M.A. Deli, Human serum amyloid P component attenuates the bacterial lipopolysaccharide-induced increase in blood-brain barrier permeability in mice, Neurosci. Lett. 352 (2003) 57-60.
30. A. Carrano, J.J. Hoozemans, S.M. van der Vies, J. van Horssen, H.E. de Vries, A.J. Rozemuller, Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy, Neurodegener. Dis. 10 (2012) 329-331.
31. Y. Wang, J. Jia, G. Ao, L. Hu, H. Liu, Y. Xiao, H. Du, N.J. Alkayed, C.F. Liu, J. Cheng, Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia, J. Neurochem. 129 (2014) 827-838.
32. S. Kanoh, T. Tanabe, B.K. Rubin, Dapsone inhibits IL-8 secretion from human bronchial epithelial cells stimulated with lipopolysaccharide and resolves airway inflammation in the ferret, Chest 140 (2011) 980-990.
33. M. Abe, A. Shimizu, Y. Yokoyama, Y. Takeuchi, O. Ishikawa, A possible inhibitory action of diaminodiphenyl sulfone on tumour necrosis factor-alpha production from activated mononuclear cells on cutaneous lupus erythematosus, Clin. Exp. Dermatol. 33 (2008) 759-763.
34. A. Frister, C. Schmidt, N. Schneble, M. Brodhun, F.A. Gonnert, M. Bauer, E. Hirsch, J.P. Muller, R. Wetzker, R. Bauer, Phosphoinositide 3-kinase gamma affects LPS-induced disturbance of blood-brain barrier via lipid kinase-independent control of cAMP in microglial cells, Neuromol. Med. (2014), in press.
35. A. Ghosh, T. Birngruber, W. Sattler, T. Kroath, M. Ratzer, F. Sinner, T.R. Pieber, Assessment of blood-brain barrier function and the neuroinflammatory response in the rat brain by using cerebral open flow microperfusion (cOFM), PLoS ONE 9 (2014) e98143.
36. T. Nishioku, S. Dohgu, F. Takata, T. Eto, N. Ishikawa, K.B. Kodama, S. Nakagawa, A. Yamauchi, Y. Kataoka, Detachment of brain pericytes from the basal lamina is involved in disruption of the blood-brain barrier caused by lipopolysaccharide-induced sepsis in mice, Cell. Mol. Neurobiol. 29 (2009) 309-316.
37. Y. Yu, L. Zhou, M. Sun, T. Zhou, K. Zhong, H. Wang, Y. Liu, X. Liu, R. Xiao, J. Ge, P. Tu, D.S. Fan, Y. Lan, C. Hui, D. Chui, Xylocoside G reduces amyloid-beta induced neurotoxicity by inhibiting NF-kappaB signaling pathway in neuronal cells, J. Alzheimer's Dis. 30 (2012) 263-275.
38. A.M. Albertsson, D. Bi, L. Duan, X. Zhang, J.W. Leavenworth, L. Qiao, C. Zhu, S. Cardell, H. Cantor, H. Hagberg, C. Mallard, X. Wang, The immune response after hypoxia-ischemia in a mouse model of preterm brain injury, J. Neuroinflamm. 11 (2014) 153.
39. Y.Y. Deng, M. Fang, G.F. Zhu, Y. Zhou, H.K. Zeng, Role of microglia in the pathogenesis of sepsis-associated encephalopathy, CNS Neurol. Disord. Drug Targets 12 (2013) 720-725.
40. P.S. Katz, J.K. Sulzer, R.A. Impastato, S.X. Teng, E.K. Rogers, P. Molina, Endocannabinoid degradation inhibition improves neurobehavioral function, blood brain barrier integrity, and neuroinflammation following mild traumatic brain injury, J. Neurotrauma (2014). in press.